Ki26894, a small molecule designed to inhibit TβR, might be a promising therapeutic agent for antagonising the metastatic phenotypes seen through autocrine TGF-β/TβR signalling in scirrhous gastric cancer. The gene discussed is TGFB1; the disease is gastric cancer.